Regulatory Submission in Europe in Absence of Reference product [Regulatives / Guidelines]

posted by drgunasakaran1  – 2021-05-20 09:20 (1014 d 11:28 ago) – Posting: # 22360
Views: 3,668

Dear Abhay Patil,

❝ The Individual product are present in Europe for more than 20 years and their equivalent Generics too available and filed under WEU. so in such case is it necessary to do BABE study


Yes. We need to conduct studies even though equivalent Individual Product Generics are available in the EU Market.

Dr S Gunasakaran MBBS MD
Disclaimer: The replies/posts are my personal opinions and it does not represent my company views on the same.

Complete thread:

UA Flag
Activity
 Admin contact
22,912 posts in 4,806 threads, 1,638 registered users;
31 visitors (0 registered, 31 guests [including 7 identified bots]).
Forum time: 19:49 CET (Europe/Vienna)

Exploratory analysis: The art of finding a Rembrandt
in a Jackson Pollock.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5